| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| ocriplasmin 375 microgram/0.3 mL intraocular injection, vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Jetrea RTU 375 microgram/0.3 mL intraocular injection, 0.3 mL vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe |
has manufactured dose form |
False |
intraocular injection |
Inferred relationship |
Some |
|
| Viscoat intraocular injection, 0.5 mL syringe |
has manufactured dose form |
False |
intraocular injection |
Inferred relationship |
Some |
|
| brolucizumab 6 mg/0.05 mL intraocular injection, syringe |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| brolucizumab 6 mg/0.05 mL intraocular injection, vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Beovu 6 mg/0.05 mL intraocular injection, 0.05 mL syringe |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Beovu 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Viscoat intraocular injection, 0.5 mL syringe |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Vsiqq 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Vabysmo 6 mg/0.05 mL intraocular injection, 0.24 mL vial |
has manufactured dose form |
False |
intraocular injection |
Inferred relationship |
Some |
|
| faricimab 6 mg/0.05 mL intraocular injection, 0.24 mL vial |
has manufactured dose form |
False |
intraocular injection |
Inferred relationship |
Some |
|
| faricimab 6 mg/0.05 mL intraocular injection, vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Vabysmo 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| carbachol 0.01% (150 microgram/1.5 mL) intraocular injection, vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|
| Miostat 0.01% (150 microgram/1.5 mL) intraocular injection, 1.5 mL vial |
has manufactured dose form |
True |
intraocular injection |
Inferred relationship |
Some |
|